Skip to main content
. 2022 Oct 1:10.1002/jmv.28163. Online ahead of print. doi: 10.1002/jmv.28163

Figure 3.

Figure 3

Comparative analysis of anti‐Wuhan, Delta, and Omicron variant receptor binding domain (RBD) antibody IgG levels in vaccinated healthy donors (HDs) and pre‐vaccinated Omicron variant‐infected patients (OIPs). (A) The anti‐Wuhan RBD antibody IgG titers in HDs at 14 days and 6 months after the second vaccine dose, 14 days after an inactivated vaccine or Ad5‐nCoV booster, and in pre‐vaccinated OIPs 7–21 days after infection. (B) The anti‐Delta RBD antibody IgG titers in HDs at 14 days and 6 months after the second vaccine dose, 14 days after an inactivated vaccine or Ad5‐nCoV booster, and in pre‐vaccinated OIPs 7–21 days after infection. (C) The anti‐Omicron RBD antibody IgG titers in HDs at 14 days and 6 months after the second vaccine dose, 14 days after an inactivated vaccine or Ad5‐nCoV booster, and in pre‐vaccinated OIPs 7–21 days after infection. (D) Paired analysis of anti‐Wuhan, Delta, and Omicron variants RBD antibody IgG titers in HDs at 14 days and 6 months after the second vaccine dose, 14 days after an inactivated vaccine or Ad5‐nCoV booster, and in pre‐vaccinated OIPs 7–21 days after infection. DPI, days postinfection; DPV, days postvaccination; GMT, geometric mean titer; IAV, inactivated vaccine. Dotted line represents the detection limits.